Updated on:
Shutdowns are a routine part of manufacturing. Plants pause for year-end holidays, scheduled maintenance, retooling, and capacity adjustments. Unplanned stops follow power failures, severe weather, and supply disruptions. In every case, quality risk concentrates at the restart.
An idle line does not stay frozen in time. Instruments drift, water sits in pipes, humidity shifts, and stored materials age. The first batches after a restart inherit all of those changes. For manufacturers in regulated sectors, post-shutdown quality control (QC) testing provides objective evidence that equipment, environments, and materials still perform as intended before product reaches customers.
What Changes While a Plant Sits Idle
1. Equipment and Instrument Drift
Measuring instruments, sensors, and process controls can drift out of tolerance during downtime, especially when temperature and humidity swing. Seals dry out, lubricants settle, and electronics restart with altered baselines. For drug manufacturers, 21 CFR 211.68 requires a written program to routinely calibrate, inspect, or check automatic, mechanical, and electronic equipment, along with records of those checks. Many quality units treat a restart as a trigger for verification rather than waiting for the next scheduled interval.
2. Water Systems and Utilities
Stagnant water is among the most underestimated shutdown risks. CDC guidance on reopening buildings after a prolonged shutdown explains that standing water can promote Legionella and other biofilm-associated bacteria, allow hot water to cool into the 77–113°F (25–42°C) growth range, and deplete disinfectant residuals. The agency also notes that Legionella risk may span weeks or months, depending on the system. Plants that rely on process water, purified water, or clean steam often build flushing, disinfectant checks, and microbiological sampling into restart protocols.
3. Sanitation and Contamination Risk
Downtime gives moisture, dust, and pests an opening. Food manufacturers face explicit expectations here. Under 21 CFR 117.35, wet-processing operations must clean and sanitize food-contact surfaces before use and after any interruption, during which those surfaces may have become contaminated. Environmental monitoring swabs, ATP verification, and pathogen testing help confirm that sanitation worked before production resumes.
4. Stored Materials and Components
Raw materials, excipients, packaging components, and in-process materials continue to age during a shutdown. A temperature excursion in an unattended warehouse can degrade sensitive ingredients, reagents, or reference standards. Retesting against specifications and reviewing storage data help identify materials that no longer meet requirements.
5. People and Procedures
Returning teams need time to settle back into routines. Skipped steps and documentation gaps tend to cluster in the first shifts after a break. Many quality teams pair restarts with brief SOP refreshers and heightened in-process checks for this reason.
Building a Risk-Based Restart Plan
Not every shutdown warrants the same response. A two-day holiday pause differs sharply from a six-week retooling project. ICH Q9(R1) Quality Risk Management, which FDA finalized in May 2023, sets out risk management principles and tools that apply across pharmaceutical quality. Quality units increasingly use the same logic to size restart testing to actual risk.
The COVID-19 pandemic offered a large-scale precedent. In September 2020, FDA issued temporary guidance on resuming normal drug and biologics manufacturing operations, which encouraged firms to assess disrupted CGMP activities, document a resumption plan, and prioritize remediation through their quality unit. The guidance was tied to the public health emergency, but its structure still mirrors how many manufacturers approach restarts today.
A typical risk-based restart moves through four checkpoints:
| Checkpoint | Typical testing and verification |
|---|---|
| Before shutdown | Calibration status review, shelf-life review of stored inventory, baseline environmental monitoring data |
| Before the first batch | Instrument verification, water system flushing and microbiological sampling, environmental swabs and ATP checks, raw material retesting |
| First production runs | Enhanced in-process sampling, full finished-product testing, comparison against pre-shutdown trend data |
| Ramp-up | Continued environmental monitoring, trend analysis, deviation and CAPA review |
A New Framework for Medical Device Manufacturers
Device makers now plan restarts under a different rulebook. The FDA’s Quality Management System Regulation (QMSR) took effect in February 2026, amending 21 CFR Part 820 to incorporate ISO 13485:2016 by reference. The FDA began inspecting under an updated device compliance program on the same date. Post-shutdown equipment verification and monitoring records now map to the ISO 13485 structure, including its controls for monitoring and measuring equipment.
Where Contract Laboratories Fit In
In-house labs often hit their own restart bottleneck. Instruments need verification, analysts return at the same time as production staff, and sample volumes spike. Third-party laboratories can absorb that surge, provide independent verification, and supply methods an in-house lab may lack, such as Legionella culture, full microbial identification, or trace contaminant analysis.
Accredited labs also deliver what auditors look for: traceable calibration, documented chain of custody, and clear method scope. These elements anchor the audit-ready deliverables clients increasingly expect from outsourced testing.
Timing matters as well. Year-end shutdowns cluster in late December, so post-shutdown testing demand clusters in early January. Manufacturers that line up lab capacity before the break avoid competing for the same turnaround slots.
Restarting With Confidence
A restart is more than flipping the power back on. It is the point where every change that accumulated during downtime meets the first production run. Manufacturers that treat restarts as a structured, risk-based quality event, backed by objective test data, protect both their products and their compliance records.
For manufacturers planning a restart, submitting a testing request allows Contract Laboratory to connect you with qualified laboratories that match your method, matrix, and documentation needs.
If your lab offers calibration, environmental monitoring, or microbiology services, register on our global network for more visibility, organic reach, and new projects.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
Frequently Asked Questions (FAQs)
It is the set of verification, environmental, and product tests a manufacturer performs before and during a restart to confirm that equipment, utilities, materials, and early batches meet established specifications.
No universal threshold exists. Risk depends on the process, product, and facility. For water systems alone, theCDC notes that Legionella risk can build over weeks or months of stagnation.
No single US rule addresses shutdowns directly. Existing obligations still apply, including drug equipment calibration under 21 CFR 211.68, food-contact sanitation under 21 CFR 117.35, and device quality system requirements under the QMSR.
Instrument calibration checks, water microbiology, environmental monitoring swabs, raw material retesting, and expanded in-process and finished-product testing.